Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

Summary

The primary objectives of this study are to assess 1) the safety and 2) efficacy of combining Anti-PD-1/PD-L1 blockade with palliative radiation therapy in patients with Stage IV Merkel Cell Carcinoma.

Timeline

Start

2019-07-24

Primary completion

2020-11-16

Completion

2021-01-20

Outcome

Outcome not reported

Stopped (Business): “Business decision”

Drugs

Indications